COSCIENS Biopharma Inc T.AEZS

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:AEZS - Post by User

COSCIENS Biopharma Inc

Bullboard Posts

Comment by plovieon Feb 27, 2007 8:26am

216 Views

Post# 12318701

RE: stock price

I agree that the stock price has been disappointing, but also agree with palnic that the company will be interested in getting the stock price significantly higher so that there is potential to raise money in 3 years. I think this is a 10 stock near year end 1st quarter of 08. Assuming there is no news in the near future that would change the companies path. Remember, the market is very forward looking. You don't buy a stock after phase 3, because you already missed the pop. People buy in anticipation of good news. We should be announcing a partner sometime in the next quarter for Perifosone.

Bullboard Posts

This battery metals stock is on a path to the global stage